{
  "slug": "nightware",
  "name": "Nightware",
  "description": "NightWare is the first and only FDA-cleared, prescription digital therapeutic system designed to reduce sleep disturbance related to Nightmare Disorder or nightmares from post-traumatic stress disorder (PTSD) in adults 22 and older.",
  "url": "https://optimly.ai/brand/nightware",
  "websiteUrl": "https://nightware.com/",
  "logoUrl": "https://logo.clearbit.com/nightware.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Digital Therapeutics (DTx) Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-25T06:22:58.108Z",
  "verifiedVitals": {
    "website": "https://nightware.com",
    "category": "Digital Therapeutics",
    "what_it_does": "NightWare is a prescription digital therapeutic system designed for the reduction of sleep disturbance related to Nightmare Disorder or nightmares from post-traumatic stress disorder (PTSD). It is the first and only FDA-cleared, prescription digital therapeutic that improves sleep in adults 22 and older with these conditions.",
    "primary_audience": "Health care professionals and patients (adults 22 and older) suffering from Nightmare Disorder or nightmares related to PTSD.",
    "core_product": "NightWare prescription digital therapeutic system"
  },
  "intentTags": {
    "problemIntents": [
      "Nightmare Disorder",
      "Nightmares from PTSD",
      "Sleep disturbance related to nightmares",
      "Severe nightmares adversely impacting sleep",
      "Need for new, effective treatments for sleep disorders"
    ],
    "solutionIntents": [
      "Prescription digital therapeutic for nightmares",
      "FDA-cleared sleep improvement system",
      "Reduction of sleep disturbance",
      "Tailored therapy for sleep patterns",
      "Low-risk treatment for nightmares",
      "Improved sleep quality",
      "Complementary treatment for PTSD"
    ],
    "evaluationIntents": [
      "FDA clearance status",
      "FDA Breakthrough Device designation",
      "Clinical trial results and evidence",
      "Safety and efficacy assessment",
      "Effectiveness in reducing sleep disturbance",
      "Compatibility with existing therapies"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1790429509170
}